Neuromeka Co., Ltd. (KOSDAQ:348340)
South Korea
· Delayed Price · Currency is KRW 23,900
+300 (1.27%)
Apr 1, 2025, 3:30 PM KST
Neuromeka Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Operating Revenue | 24,784 | 13,743 | 9,755 | 7,351 | 4,066 | Upgrade
|
| Other Revenue | 485.88 | - | - | -0 | - | Upgrade
|
| Revenue | 25,269 | 13,743 | 9,755 | 7,351 | 4,066 | Upgrade
|
| Revenue Growth (YoY) | 83.87% | 40.89% | 32.69% | 80.81% | -43.63% | Upgrade
|
| Cost of Revenue | 21,209 | 12,580 | 8,672 | 5,555 | 3,844 | Upgrade
|
| Gross Profit | 4,061 | 1,163 | 1,083 | 1,797 | 221.53 | Upgrade
|
| Selling, General & Admin | 11,597 | 8,285 | 6,211 | 2,935 | 2,804 | Upgrade
|
| Research & Development | 6,620 | 5,264 | 1,923 | 931.67 | 3,816 | Upgrade
|
| Other Operating Expenses | 485.04 | 253.64 | 242.51 | 123.31 | 194.65 | Upgrade
|
| Operating Expenses | 23,499 | 15,989 | 8,892 | 4,806 | 8,376 | Upgrade
|
| Operating Income | -19,439 | -14,825 | -7,809 | -3,009 | -8,154 | Upgrade
|
| Interest Expense | -4,929 | -2,050 | -292 | -532.95 | -481.31 | Upgrade
|
| Interest & Investment Income | 626.1 | 1,097 | 315.7 | 57.4 | 52.64 | Upgrade
|
| Earnings From Equity Investments | 24.55 | -27.31 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 24.66 | 99.84 | 72.27 | 115.2 | -103.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 6,472 | -2,150 | -487.07 | -3,201 | 415.12 | Upgrade
|
| EBT Excluding Unusual Items | -17,221 | -17,856 | -8,201 | -6,570 | -8,271 | Upgrade
|
| Gain (Loss) on Sale of Investments | 494.01 | 282.13 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.36 | -72.2 | - | -23.88 | - | Upgrade
|
| Pretax Income | -16,724 | -17,646 | -8,201 | -6,594 | -8,271 | Upgrade
|
| Income Tax Expense | 30.57 | 7.1 | - | - | - | Upgrade
|
| Net Income | -16,755 | -17,654 | -8,201 | -6,594 | -8,271 | Upgrade
|
| Net Income to Common | -16,755 | -17,654 | -8,201 | -6,594 | -8,271 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 10 | 9 | 7 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 10 | 9 | 7 | 1 | Upgrade
|
| Shares Change (YoY) | 1.18% | 21.11% | 19.56% | 440.13% | 168.49% | Upgrade
|
| EPS (Basic) | -1589.00 | -1694.00 | -953.00 | -916.23 | -6207.24 | Upgrade
|
| EPS (Diluted) | -1589.00 | -1694.00 | -953.00 | -916.23 | -6207.24 | Upgrade
|
| Free Cash Flow | -35,625 | -42,925 | -11,008 | -1,267 | -4,121 | Upgrade
|
| Free Cash Flow Per Share | -3378.64 | -4118.99 | -1279.29 | -175.97 | -3092.46 | Upgrade
|
| Gross Margin | 16.07% | 8.46% | 11.10% | 24.44% | 5.45% | Upgrade
|
| Operating Margin | -76.93% | -107.88% | -80.06% | -40.93% | -200.57% | Upgrade
|
| Profit Margin | -66.30% | -128.46% | -84.07% | -89.70% | -203.44% | Upgrade
|
| Free Cash Flow Margin | -140.98% | -312.34% | -112.85% | -17.23% | -101.35% | Upgrade
|
| EBITDA | -17,117 | -13,819 | -6,908 | -2,120 | -7,179 | Upgrade
|
| EBITDA Margin | -67.74% | -100.55% | -70.82% | -28.84% | -176.57% | Upgrade
|
| D&A For EBITDA | 2,322 | 1,007 | 901.29 | 888.92 | 975.59 | Upgrade
|
| EBIT | -19,439 | -14,825 | -7,809 | -3,009 | -8,154 | Upgrade
|
| EBIT Margin | -76.93% | -107.88% | -80.06% | -40.93% | -200.57% | Upgrade
|
| Advertising Expenses | 764.89 | 605.54 | 145.27 | 27.26 | 27.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.